Reg3A (regenerating family member 3 alpha) acts as a tumor suppressor by targeting DMBT1 (deleted in malignant brain tumors 1) in gastric cancer

References

• Kim Y, Choi JW, Lee JH, et al. Spindle assembly checkpoint MAD2 and CDC20 overexpressions and cell-in-cell formation in gastric cancer and its precursor lesions. Hum Pathol. 2019Mar;85:174–183.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol. 2015 Jul;1(4):505–527.
   PubMed Web of Science ®Google Scholar
• Fidler MM, Bray F, Soerjomataram I. The global cancer burden and human development: a review. Scand J Public Health. 2018 Feb;46(1):27–36.
   PubMed Web of Science ®Google Scholar
• Diaz Del Arco C, Estrada Munoz L, Molina Roldan E, et al. Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival. Virchows Arch. 2018 Dec;473(6):687–695.
   PubMed Web of Science ®Google Scholar
• Gao Y, Qi W, Sun L, et al. FOXO3 Inhibits Human Gastric Adenocarcinoma (AGS) cell growth by promoting autophagy in an acidic microenvironment. Cell Physiol Biochem. 2018;49(1):335–348.
   PubMedGoogle Scholar
• Qiu YS, Liao GJ, Jiang NN. REG3A overexpression suppresses gastric cancer cell invasion, proliferation and promotes apoptosis through PI3K/Akt signaling pathway. Int J Mol Med. 2018 Jun;41(6):3167–3174.
   PubMed Web of Science ®Google Scholar
• You G, Cao H, Yan L, et al. MicroRNA-10a-3p mediates Th17/Treg cell balance and improves renal injury by inhibiting REG3A in lupus nephritis. Int Immunopharmacol. 2020Nov;88:106891.
   PubMed Web of Science ®Google Scholar
• Jiang T, Huang Y, Liu H, et al. Reduced miR-146a promotes REG3A expression and macrophage migration in polymyositis and dermatomyositis. Front Immunol. 2020;11:37.
   PubMed Web of Science ®Google Scholar
• Fan H, Wang Y, Zhang X, et al. Ginsenoside compound K ameliorates imiquimod-induced psoriasis-like dermatitis through inhibiting REG3A/RegIIIgamma expression in keratinocytes. Biochem Biophys Res Commun. 2019 Aug 6;515(4):665–671.
   PubMed Web of Science ®Google Scholar
• Yari H, Jin L, Teng L, et al. LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription. Nat Commun. 2019 Nov 25;10(1):5334.
   PubMedGoogle Scholar
• Liu X, Wang J, Wang H, et al. REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: involvement of a REG3A-JAK2/STAT3 positive feedback loop. Cancer Lett. 2015 Jun 28;362(1):45–60.
   PubMed Web of Science ®Google Scholar
• Ye Y, Xiao L, Wang SJ, et al. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk. Oncotarget. 2016 Jan 26;7(4):3921–3933.
   PubMedGoogle Scholar
• Cho Y, Park MJ, Kim K, et al. Tumor-stroma crosstalk enhances REG3A expressions that drive the progression of hepatocellular carcinoma. Int J Mol Sci. 2020 Jan 11;21(2). DOI:10.3390/ijms21020472.
   Web of Science ®Google Scholar
• Cui P, Su J, Li Q, et al. LncRNA RHPN1-AS1 targeting miR-625/REG3A promotes cell proliferation and invasion of glioma cells. Onco Targets Ther. 2019;12:7911–7921.
   PubMed Web of Science ®Google Scholar
• Mollenhauer J, Helmke B, Muller H, et al. Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas. Genes Chromosomes Cancer. 2002 Oct;35(2):164–169.
   PubMed Web of Science ®Google Scholar
• Mollenhauer J, Herbertz S, Holmskov U, et al. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res. 2000 Mar 15;60(6):1704–1710.
   PubMed Web of Science ®Google Scholar
• Blackburn AC, Hill LZ, Roberts AL, et al. Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol. 2007 Jun;170(6):2030–2041.
   PubMed Web of Science ®Google Scholar
• Park HS, Kim BC, Yeo HY, et al. Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer. Oncol Rep. 2018 May;39(5):2279–2287.
   PubMed Web of Science ®Google Scholar
• Du J, Guan M, Fan J, et al. Loss of DMBT1 expression in human prostate cancer and its correlation with clinical progressive features. Urology. 2011 Feb;77(2):509e9–13.
   Web of Science ®Google Scholar
• Sheng S, Jiwen W, Dexiang Z, et al. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN. Biosci Biotechnol Biochem. 2019;83(12):2257–2264.
   PubMed Web of Science ®Google Scholar
• Imai MA, Moriya T, Imai FL, et al. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma. Int J Mol Med. 2005 Apr;15(4):585–589.
   PubMed Web of Science ®Google Scholar
• Ma N, Zhao Y. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway. Cell Biochem Funct. 2020 Aug;38(6):801–809.
   PubMed Web of Science ®Google Scholar
• Kang W, Nielsen O, Fenger C, et al. Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer. Carcinogenesis. 2005 Jun;26(6):1129–1137.
   PubMed Web of Science ®Google Scholar
• Baker S, Ali I, Silins I, et al. Cancer Hallmarks Analytics Tool (CHAT): a text mining approach to organize and evaluate scientific literature on cancer. Bioinformatics. 2017 Dec 15;33(24):3973–3981.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017 Jul 3;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Szasz AM, Lanczky A, Nagy A, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016 Aug 2;7(31):49322–49333.
   PubMedGoogle Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018 Jan 4;46(D1):D956–D963.
   PubMed Web of Science ®Google Scholar
• Wirz A, Mandillo S, D’Amato FR, et al. Response, use and habituation to a mouse house in C57BL/6J and BALB/c mice. Exp Anim. 2015;64(3):281–293.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H, Han Y, et al. SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med (Berl). 2014 Dec;92(12):1257–1269.
   PubMed Web of Science ®Google Scholar
• Taftachi R, Ayhan A, Ekici S, et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67. BJU Int. 2005 Mar;95(4):650–654.
   PubMed Web of Science ®Google Scholar
• Chen ZF, Huang ZM, Xue HB, et al. REG3A promotes the proliferation, migration, and invasion of gastric cancer cells. Onco Targets Ther. 2017;10:2017–2023.
   PubMed Web of Science ®Google Scholar
• Conde AR, Martins AP, Brito M, et al. DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types. Int J Oncol. 2007 Jun;30(6):1441–1446.
   PubMed Web of Science ®Google Scholar
• Sousa JF, Ham AJ, Whitwell C, et al. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol. 2012 Nov;181(5):1560–1572.
   PubMed Web of Science ®Google Scholar
• Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248.
   PubMed Web of Science ®Google Scholar
• Isobe Y, Nashimoto A, Akazawa K, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011 Oct;14(4):301–316.
   PubMed Web of Science ®Google Scholar